Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies. 2012

Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
Natural Products Research Laboratories and ‡Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina , Chapel Hill, North Carolina 27599-7568, United States.

Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D010618 Phenanthrolines Phenanthroline
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
October 2015, Journal of medicinal chemistry,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
March 1982, Journal of medicinal chemistry,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
May 2013, European journal of organic chemistry,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
January 2007, Bioorganic & medicinal chemistry letters,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
January 2024, Molecules (Basel, Switzerland),
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
September 2018, Molecules (Basel, Switzerland),
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
February 2013, Bioorganic & medicinal chemistry,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
March 1992, Chemical & pharmaceutical bulletin,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
January 2015, Anti-cancer agents in medicinal chemistry,
Xiaoming Yang, and Qian Shi, and Chin-Yu Lai, and Chi-Yuan Chen, and Emika Ohkoshi, and Shuenn-Chen Yang, and Chih-Ya Wang, and Kenneth F Bastow, and Tian-Shung Wu, and Shiow-Lin Pan, and Che-Ming Teng, and Pan-Chyr Yang, and Kuo-Hsiung Lee
March 1990, Journal of medicinal chemistry,
Copied contents to your clipboard!